Thomas Edward Hamilton is Director of Larimar Therapeutics, Inc.. Currently has a direct ownership of 564,798 shares of LRMR, which is worth approximately $2.25 Million. The most recent transaction as insider was on Feb 16, 2024, when has been sold 57,208 shares (Common Stock) at a price of $8.74 per share, resulting in proceeds of $499,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 565K
0% 3M change
11.27% 12M change
Total Value Held $2.25 Million

Thomas Edward Hamilton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2024
BUY
Open market or private purchase
$499,997 $8.74 p/Share
57,208 Added 9.2%
564,798 Common Stock
Sep 16 2022
BUY
Open market or private purchase
$999,999 $3.15 p/Share
317,460 Added 38.48%
507,590 Common Stock
Jun 30 2021
BUY
Open market or private purchase
$496,212 $8.75 p/Share
56,710 Added 22.97%
190,130 Common Stock

Also insider at

NLY
ANNALY CAPITAL MANAGEMENT INC Real Estate
TEH

Thomas Edward Hamilton

Director
Bala Cynwyd, PA

Track Institutional and Insider Activities on LRMR

Follow Larimar Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LRMR shares.

Notify only if

Insider Trading

Get notified when an Larimar Therapeutics, Inc. insider buys or sells LRMR shares.

Notify only if

News

Receive news related to Larimar Therapeutics, Inc.

Track Activities on LRMR